Priyanka Jaju Acquires Convertible Warrants in Godavari Drugs Ltd.
Godavari Drugs Limited announced that Priyanka Jaju, a promoter of the company, acquired 1,00,000 convertible warrants through a preferential issue on March 18, 2026.The acquisition was made via preferential allotment. Prior to the acquisition, Jaju held 1,85,000 shares representing 2.46% of the company's total share/voting capital. Following the acquisition of the warrants, Jaju's holding increased, with a total of 2,85,000 shares representing 1.83% of the company’s total share/voting capital and 2.28% in warrants.
Godavari Drugs Limited’s total share capital stands at Rs. 7,53,05,000, divided into 75,30,500 fully paid-up equity shares of Rs. 10 each. The total diluted share/voting capital of the company is Rs. 12,48,75,000, divided into 1,24,87,500 fully paid-up equity shares of Rs. 10 each.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Last edited by a moderator: